Literature DB >> 23220186

Glucose-dependent insulinotropic polypeptide receptor deficiency leads to modifications of trabecular bone volume and quality in mice.

Christine Gaudin-Audrain1, Nigel Irwin, Sity Mansur, Peter R Flatt, Bernard Thorens, Michel Baslé, Daniel Chappard, Guillaume Mabilleau.   

Abstract

A role for the gastro-intestinal tract in controlling bone remodeling is suspected since serum levels of bone remodeling markers are affected rapidly after a meal. Glucose-dependent insulinotropic polypeptide (GIP) represents a suitable candidate in mediating this effect. The aim of the present study was to investigate the effect of total inhibition of GIP signaling on trabecular bone volume, microarchitecture and quality. We used GIP receptor (GIPR) knockout mice and investigated trabecular bone volume and microarchitecture by microCT and histomorphometry. GIPR-deficient animals at 16 weeks of age presented with a significant (20%) increase in trabecular bone mass accompanied by an increase (17%) in trabecular number. In addition, the number of osteoclasts and bone formation rate was significantly reduced and augmented, respectively in these animals when compared with wild-type littermates. These modifications of trabecular bone microarchitecture are linked to a remodeling in the expression pattern of adipokines in the GIPR-deficient mice. On the other hand, despite significant enhancement in bone volume, intrinsic mechanical properties of the bone matrix was reduced as well as the distribution of bone mineral density and the ratio of mature/immature collagen cross-links. Taken together, these results indicate an increase in trabecular bone volume in GIPR KO animals associated with a reduction in bone quality.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23220186     DOI: 10.1016/j.bone.2012.11.039

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  21 in total

Review 1.  The hunger games of skeletal metabolism.

Authors:  Natalie K Y Wee; Paul A Baldock
Journal:  Bonekey Rep       Date:  2014-11-12

Review 2.  Glucagon-like peptide 1 (GLP-1).

Authors:  T D Müller; B Finan; S R Bloom; D D'Alessio; D J Drucker; P R Flatt; A Fritsche; F Gribble; H J Grill; J F Habener; J J Holst; W Langhans; J J Meier; M A Nauck; D Perez-Tilve; A Pocai; F Reimann; D A Sandoval; T W Schwartz; R J Seeley; K Stemmer; M Tang-Christensen; S C Woods; R D DiMarchi; M H Tschöp
Journal:  Mol Metab       Date:  2019-09-30       Impact factor: 7.422

Review 3.  Influence of hormonal appetite and energy regulators on bone.

Authors:  Ee Cheng Khor; Natalie Kah Yun Wee; Paul A Baldock
Journal:  Curr Osteoporos Rep       Date:  2013-09       Impact factor: 5.096

4.  Strontium ranelate stimulates trabecular bone formation in a rat tibial bone defect healing process.

Authors:  C Lavet; G Mabilleau; D Chappard; R Rizzoli; P Ammann
Journal:  Osteoporos Int       Date:  2017-09-28       Impact factor: 4.507

5.  Double incretin receptor knock-out (DIRKO) mice present with alterations of trabecular and cortical micromorphology and bone strength.

Authors:  A Mieczkowska; S Mansur; B Bouvard; P R Flatt; B Thorens; N Irwin; D Chappard; G Mabilleau
Journal:  Osteoporos Int       Date:  2014-08-16       Impact factor: 4.507

6.  Evaluation of Serum Glucagon-Like Peptide 1 and Vitamin D Levels in Elderly Patients with Bone Fractures.

Authors:  Özhan Pazarci; Halef Okan Dogan; Seyran Kilinc; Yalkin Çamurcu
Journal:  Med Princ Pract       Date:  2019-07-17       Impact factor: 1.927

7.  Glucose-Dependent Insulinotropic Peptide Prevents Serum Deprivation-Induced Apoptosis in Human Bone Marrow-Derived Mesenchymal Stem Cells and Osteoblastic Cells.

Authors:  J L Berlier; I Kharroubi; J Zhang; A Dalla Valle; S Rigutto; M Mathieu; V Gangji; J Rasschaert
Journal:  Stem Cell Rev Rep       Date:  2015-12       Impact factor: 5.739

Review 8.  New perspectives on exploitation of incretin peptides for the treatment of diabetes and related disorders.

Authors:  Nigel Irwin; Peter R Flatt
Journal:  World J Diabetes       Date:  2015-11-10

9.  Incretin action on bone: An added benefit?

Authors:  Ronald C W Ma; Gang Xu
Journal:  J Diabetes Investig       Date:  2014-09-15       Impact factor: 4.232

Review 10.  Landmark studies on the glucagon subfamily of GPCRs: from small molecule modulators to a crystal structure.

Authors:  De-hua Yang; Cai-hong Zhou; Qing Liu; Ming-wei Wang
Journal:  Acta Pharmacol Sin       Date:  2015-08-17       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.